| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |